Causal inference framework for personalised b/tsDMARD selection in rheumatoid arthritis: ANSWER cohort validation
Kosuke Kita, Kosuke Ebina, Yuki Suzuki, Yuki Etani et autres
0 citationsnpj Digital Medicine
Kohei Tsujimoto
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
42Publications signalées
374Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Rheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchVasculitis and related conditionsInflammasome and immune disordersAutoimmune and Inflammatory Disorders Research
Publications récentes
Real-world comparison of herpes zoster risk among five Janus kinase inhibitors in rheumatoid arthritis: The ANSWER cohort study
Yuki Etani, Yasutaka Okita, Yuichi Maeda, Kohei Tsujimoto et autres
0 citationsJoint Bone Spine
A causal inference framework for personalised b/tsDMARD selection in rheumatoid arthritis: multi-centre development and external validation from the ANSWER cohort
Kosuke Kita, Kosuke Ebina, Y Suzuki, Yuki Etani et autres
0 citationsResearch Square
Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohort
Yuki Etani, Yasutaka Okita, Kohei Tsujimoto, Takaaki Noguchi et autres
0 citationsClinical Rheumatology
Peripheral blood UBA1 variant burden predicts poor outcomes in VEXAS syndrome: a nationwide prospective study
Yohei Kirino, Ayaka Maeda, Kana Higashitani, Nobuyuki Horita et autres
2 citationsAnnals of the Rheumatic Diseases
Mode of action-specific and cause-specific retention of biologic and targeted synthetic disease-modifying antirheumatic drugs in anti-SS-A antibody-positive rheumatoid arthritis: The ANSWER cohort study
Kazuma Nishisaka, T. Okano, Takumi Imai, Masanori Tsubosaka et autres
0 citationsPLoS ONE
Identification of Histone Deacetylase Inhibitor Targeting Type I Interferon and B Cell Abnormalities in Systemic Lupus Erythematosus
Takehiro Hirayama, Hachiro Konaka, Yasuhiro Kato, Takayuki Shibahara et autres
1 citationArthritis & Rheumatology
Mode of action- and cause-specific drug retention of b/tsDMARDs in anti-SS-A antibody-positive rheumatoid arthritis: the ANSWER cohort study
Kazuma Nishisaka, T. Okano, Takumi Imai, Masanori Tsubosaka et autres
0 citationsResearch Square
Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study
Yuji Nozaki, Koichi Murata, Akira Ōnishi, Kohei Tsujimoto et autres
4 citationsLara D. Veeken
Distinct trajectories of humoral immune responses after SARS-CoV-2 mRNA vaccination in autoimmune inflammatory rheumatic diseases: A group-based trajectory analysis
Yuta Yamaguchi, Saori Amiya, Shoichiro Inokuchi, Sayaka Nagao et autres
0 citationsVaccine
Differential Impact of Concomitant Methotrexate and Glucocorticoids Dosages on Biologics and JAK Inhibitors: The ANSWER Cohort Study
Kosuke Ebina, Yuki Etani, Yasutaka Okita, Kohei Tsujimoto et autres
2 citationsInternational Journal of Rheumatic Diseases
Single-cell analysis reveals immune cell abnormalities underlying the clinical heterogeneity of patients with systemic sclerosis
Hiroshi Shimagami, Kei Nishimura, Hiroaki Matsushita, Shoichi Metsugi et autres
22 citationsNature Communications
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.